MemoryPlus Israeli Company
MemoryPlus is pioneering an innovative treatment targeting Alzheimer’s-related cognitive decline, leveraging a novel mechanism of action (MOA). Its research is based on groundbreaking work from Prof. Shira Knafo, who discovered that the PTEN protein plays a critical role in memory decline by inhibiting neuronal activity. By disrupting the interaction between PTEN and PDZ domain proteins, the company has the potential to restore memory function.
Health Tech & Life Sciences
Health Care
Health Diagnostics
Medical
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Rehovot, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/memoryplus
[2]
crunchbase.com
- https://www.crunchbase.com/organization/memoryplus
External links are provided for reference and verification purposes.